Sionna Therapeutics (SION) Other Accumulated Expenses (2025 - 2026)
Quarterly results put Other Accumulated Expenses at $17000.0 for Q1 2026, changed N/A from a year ago — trailing twelve months through Mar 2026 was $17000.0 (changed N/A YoY), and the annual figure for FY2025 was $6000.0, changed.
Sionna Therapeutics has reported Other Accumulated Expenses over the past 2 years, most recently at $17000.0 for Q1 2026.
- Other Accumulated Expenses reached $17000.0 in Q1 2026 per SION's latest filing, up from $6000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $224000.0 in Q3 2025 and bottomed at $6000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Sionna Therapeutics | 1.87 Bn | 1.87 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | 224,000.00 |